University of California San Francisco Give to UCSF

Beyond PSMA Lutetium Approval: the Unanswered Questions

Organizer: Eric Small, MD

This workshop will be an online event open to registered attendees. Presentation topics will cover clinical implications of approval for 177Lu-PSMA-617, modulation of PSMA expression, PSMA-lutetium and immunotherapy, and PSMA-targeted alpha particle therapy.

Workshop Presentations:

  • Louise Emmett, MD 
    Professor, University of New South Wales
    Director, Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney 
    Mix ‘n Match: Optimizing PSMA Targeted Therapy.... Or Not? 
  • Vadim Koshkin, MD 
    PSMA-Lutetium: Clinical Implications and Unanswered Questions  
  • Luke Gilbert, PhD and Vadim Koshkin, MD 
    Regulation of PSMA Expression and Clinical Implications 
  • Rahul Aggarwal, MD 
    Clinical Trial: PSMA-Lutetium and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate Cancer 
  • Lawrence Fong, MD 
    CyTOF Results from PSMA-Lutetium and Pembrolizumab Trial 
  • Thomas Hope, MD 
    Beyond Lutetium: PSMA-Actinium  

Open to the UCSF research community. Please register to attend by Nov 15.

Event Details

  • Henry VanBrocklin
  • Huadong CHEN

2 people are interested in this event


Members of the UCSF research community may register HERE.